share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

SEC announcement ·  Jun 29 04:09
Summary by Futu AI
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.